Transcat stock enters investor meetings after earnings beat estimates
Transcat (TRNS) stock is heading into investor meetings after reporting strong quarterly earnings, beating revenue and EPS estimates on August 4, 2026. The company, which provides calibration and repair services, will engage with institutional investors at upcoming conferences, following a 7.4% revenue beat and an EPS of $0.51 against a $0.38 consensus. Despite the positive earnings, the stock was trading below its yearly high, making these investor meetings crucial for future market commentary.
Transcat, Inc. (TRNS) Stock Price, News, Quote & History
This article provides an overview of Transcat, Inc. (TRNS), including its current stock price, recent performance metrics, and key financial data. It details the company's business segments—Service and Distribution—and its offerings in calibration and laboratory instrument services for highly regulated industries. The report also includes analyst price targets and a summary of recent earnings trends.
Transcat stock gains 2.51 percent as growth meets valuation
Transcat stock increased by 2.51 percent, reaching USD 88.16 on September 22, 2026, with a market capitalization of USD 825.161 million. The stock's six-month return was 21.9 percent, outperforming the S&P 500, but its forward P/E of 43.8 highlights the need for earnings growth to keep pace with valuation. While revenue grew at 13.8% annually over five years, EPS growth was only 4.1%, indicating a gap that could impact future appreciation.
Transcat stock holds at USD 86.00 as earnings growth builds
Transcat stock was quoted at USD 86.00 on Nasdaq as of September 21, 2026, with a market capitalization of USD 804.944 million, placing it in the small-cap segment. The article highlights that while the company's historical fiscal year 2021 third-quarter figures show quarterly revenue of USD 217.41 million, it also reported negative earnings of USD 91.18 million, leading to a negative profit margin. The author emphasizes that for a small-cap company like Transcat, earnings quality is a critical analytical variable, and future valuation signals will depend on whether revenue growth translates into positive earnings and a stronger margin.
Transcat, Inc. Announces 2026 Annual Meeting Shareholder Voting Results
Transcat, Inc. (NASDAQ:TRNS) held its annual shareholder meeting on September 9, 2026, and disclosed the voting results on September 10, 2026. Shareholders elected six directors for one-year terms, approved executive compensation in an advisory vote, and ratified Deloitte & Touche LLP as the independent auditor for the fiscal year ending March 27, 2027. Robert L. Mecca received the most votes among the elected directors.
RSU awards lift Transcat (TRNS) director to 2,291 shares
Transcat director Robert Mecca's recent equity compensation activity, detailed in a Form 4 filing, shows he received 1,671 Restricted Stock Units (RSUs) on September 9, 2026, which vest on September 9, 2027. On September 10, 2026, 1,587 RSUs vested and converted into common shares, increasing his direct holdings to 2,291 common shares. Additionally, Mecca holds a stock option for 10,000 shares with an exercise price of $98.88, vesting pro rata over five years and expiring on January 24, 2034.
New RSU grant and vesting reported by Transcat (TRNS) director
Transcat (TRNS) director Gary J. Haseley reported equity compensation activity, including a new grant of 1,671 Restricted Stock Units (RSUs) on September 9, 2026, which will vest on September 9, 2027. Additionally, 1,587 previously granted RSUs vested and converted into common stock on September 10, 2026, increasing his direct holdings to 40,689 shares. He also holds 1,200 shares indirectly through family trusts.
Transcat Inc Director Oksana Dominach Reports Stock Sale and RSU Grant in September 2026 SEC Filing
Transcat Inc. Director Oksana S. Dominach reported a stock sale and a restricted stock unit (RSU) grant in a September 2026 SEC filing. Dominach sold 7,312 shares of common stock at $85.5958 per share on September 2, 2026, and subsequently owned 4,346 shares. She also received a grant of 1,587 RSUs, set to vest on September 10, 2026.
Transcat, Inc. acquired Southeastern Biomedical Associates, Inc. for $12.8 million.
Transcat, Inc. (NasdaqGM:TRNS) has acquired Southeastern Biomedical Associates, Inc. for $12.8 million. The acquisition was completed on August 31, 2026. Transcat specializes in accredited calibration, reliability, and maintenance optimization services for highly regulated industries like life science, aerospace, and energy.
Transcat Acquires Southeastern Biomedical Associates For $12.8 Million
Transcat, Inc. has acquired Southeastern Biomedical Associates, Inc. for $12.8 million. The acquisition was reported on August 31, 2026, and is part of Transcat's strategy to expand its service offerings. Transcat specializes in accredited calibration and related services for highly regulated industries.
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
Transcat, Inc. has acquired Southeastern Biomedical Associates Incorporated for $12.8 million in cash. This acquisition expands Transcat's accredited biomedical calibration capabilities, equipment repair, and preventative maintenance services, strengthening its presence with hospital networks and healthcare facilities in the Southeastern United States. The former owners of Southeastern Biomedical will remain with Transcat to help drive the growth of the combined biomedical business.
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
Transcat, Inc. (Nasdaq: TRNS) announced its management will attend three investor conferences in September 2026: the Jefferies Global Industrials Conference, Lake Street Capital Markets BIG10 Conference, and D.A. Davidson Diversified Industrials & Services Conference. President and CEO Jaime Irick and CFO Thomas Barbato will host one-on-one meetings and a presentation, while Barbato and Director of Finance John Howe will also participate in meetings. The company aims to engage with institutional investors and highlight its leadership in test measurement, control, and calibration services.
Transcat's (NASDAQ:TRNS) Conservative Accounting Might Explain Soft Earnings
The article suggests that Transcat's seemingly soft earnings might be a result of its conservative accounting practices, which could be obscuring the company's true financial health. Investors might be overlooking the underlying strength of the business due to these reporting methods. It implies that a deeper analysis beyond the surface-level earnings report is necessary to understand Transcat's actual performance.
Transcat's (NASDAQ:TRNS) Conservative Accounting Might Explain Soft Earnings
This article suggests that Transcat's seemingly soft earnings might be due to its conservative accounting practices, specifically its approach to capitalizing software development costs. The author argues that if the company were to use a more aggressive accounting method, its reported earnings would appear significantly higher.
Transcat director exercises options on 10,000 shares | TRNS Insider Trading
Transcat director Oksana S. Dominach exercised stock options for 10,000 shares of common stock at an exercise price of $26.27 per share on August 13, 2026. A portion of these shares (2,688) was delivered or withheld to cover the exercise price or tax liability. Following these transactions, Dominach holds 1,587 Restricted Stock Units that are set to vest on September 10, 2026.
5 Revealing Analyst Questions From Transcat’s Q2 Earnings Call
Transcat (TRNS) exceeded Q2 revenue and profit expectations, driven by strong performance in regulated markets like life sciences, aerospace, and energy. The earnings call highlighted key analyst questions covering end-market performance, AI productivity, service growth confidence, operating expense investments, and the sustainability of service margin gains. Management addressed these points, emphasizing broad-based growth, future operational improvements, and strategic investments.
Transcat (NASDAQ:TRNS) Director Sells 504 Shares of Stock
Transcat (NASDAQ:TRNS) Director Christopher Gillette sold 504 shares of the company's stock for approximately $47,492, significantly reducing his direct ownership. This sale occurred as Transcat shares rose 2.5% to $97.76, nearing their 12-month high, following a quarter where the company surpassed earnings and revenue expectations. Analysts currently hold an average "Hold" rating with a target price of $105.50 for TRNS.
Transcat Inc (TRNS) director sells 504 shares, reports RSUs and options
Transcat Inc. director Christopher P. Gillette sold 504 shares of common stock at $94.2345 per share, retaining 200 shares. Additionally, he reported holding 1,587 restricted stock units vesting on September 10, 2026, and 10,000 stock options with an exercise price of $109.55 expiring in 2033. This insider transaction was filed on August 12, 2026, following the sale on August 7, 2026.
Sei Investments Co. Decreases Holdings in Transcat, Inc. $TRNS
Sei Investments Co. significantly reduced its stake in Transcat, Inc. (NASDAQ:TRNS) by 46.7% in the first quarter, selling 16,136 shares and retaining 18,397 shares valued at $1.35 million. Despite this reduction, Transcat reported strong quarterly earnings of $0.51 per share and revenue of $92.95 million, both exceeding analyst expectations. Institutional investors collectively own 98.34% of the company, and Transcat's stock is currently trading near its 52-week high, with analysts maintaining a "Hold" rating and a price target of $105.50.
Some May Be Optimistic About Transcat's (NASDAQ:TRNS) Earnings
Transcat's recent soft earnings did not alarm shareholders, as underlying positive factors seem to be counterbalancing the headline numbers. The company's statutory profit was reduced by US$3.8 million due to unusual one-off items, suggesting that future profits could be higher if these expenses do not recur. This indicates that Transcat's reported earnings might be understating its true potential.
Transcat (TRNS) Q1 2027 Earnings Call Transcript
Transcat (TRNS) reported strong Q1 2027 results with consolidated revenue up 22% to $92.9 million, driven by double-digit growth in both its Service and Distribution segments. The company highlighted 13% Service organic revenue growth and expanding service gross margins, attributed to operational leverage and maturing customer relationships. CEO Jaime Irick emphasized a new focus on operational excellence alongside continued organic and inorganic growth strategies, including strategic acquisitions and the use of technology like AI for productivity gains.
Transcat (NASDAQ:TRNS) Trading Up 7.7% on Insider Buying Activity
Transcat (NASDAQ:TRNS) shares surged 7.7% following an insider purchase by director Craig D. Cairns, who bought 1,050 shares worth approximately $98,669, significantly increasing his direct stake. The company also surpassed quarterly earnings expectations with an EPS of $0.51 and revenue of $92.95 million. Analyst sentiment is generally a "Hold" with a consensus price target of $105.50, and institutional investors hold a substantial 98.34% of the outstanding shares.
Transcat Inc (TRNS) Stock News Today
This article provides current stock information for Transcat Inc (TRNS), including its latest stock price, market capitalization, and P/E ratio. It indicates that more news, earnings, and analyst ratings for TRNS are expected soon.
Craig Cairns Buys 1,050 Shares of Transcat (NASDAQ:TRNS) Stock
Director Craig Cairns recently acquired 1,050 shares of Transcat (NASDAQ:TRNS) stock for $98,668.50, increasing his stake by over 244%. This insider buying occurred despite a 2.3% drop in Transcat's stock price, even though the company surpassed earnings and revenue estimates for its latest quarter. Analysts currently maintain a "Hold" rating for TRNS with a consensus target price of $105.50.
Transcat (TRNS) director Craig Cairns buys 1,050 shares, reports sizeable options
Transcat Inc. director Craig D. Cairns purchased 1,050 shares of common stock at $93.965 per share on August 6, 2026, through his 401(k) plan. This transaction increased his indirect holdings in that account to 1,480 shares, in addition to his direct and other indirect holdings, and significant stock options and restricted stock units. The filing indicates a positive sentiment regarding the transaction, which was not made under a Rule 10b5-1 plan.
5 Revealing Analyst Questions From Transcat’s Q2 Earnings Call
Transcat (TRNS) exceeded Q2 revenue and profit expectations, driven by strong performance in its Service and Distribution segments, particularly in regulated markets. Analysts questioned management on sustained growth in rental business, AI productivity timelines, service growth confidence, operating expense investments, and the sustainability of service margin gains. The company highlighted broad-based market performance, operational improvements, and strategic investments in talent and technology.
Royal Bank of Canada Has $9.73 Million Stock Holdings in Transcat, Inc. $TRNS
Royal Bank of Canada decreased its stake in Transcat, Inc. by 17.6% in the first quarter, now holding 132,447 shares valued at $9.73 million. Despite Transcat exceeding Q2 earnings and revenue expectations, analyst sentiment remains cautious, with Northland downgrading the stock to "Market Perform" and revising down future EPS forecasts due to an elevated P/E ratio. Institutional investors collectively own 98.34% of Transcat.
Renaissance Technologies LLC Cuts Stock Position in Transcat, Inc. $TRNS
Renaissance Technologies LLC significantly reduced its stake in Transcat, Inc. (NASDAQ:TRNS) by 63.6% in the first quarter, selling 60,500 shares and retaining 34,700 shares valued at approximately $2.55 million. Despite Transcat reporting an earnings and revenue beat, analyst sentiment remains cautious, with an average "Hold" rating and Northland downgrading the stock and lowering future EPS forecasts. The stock's high trailing P/E ratio above 250 also contributes to a negative sentiment, especially with recent downward revisions to earnings estimates.
Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call
Transcat, Inc. announced it will host a conference call and webcast on Tuesday, May 26, 2026, at 4:30 p.m. ET to discuss its fourth quarter fiscal year 2026 financial results. The company's President and CEO Jaime Irick and CFO Thomas Barbato will review the results and provide an outlook. Details for accessing the call and webcast, along with replay information, have been provided for investors and interested parties.
Results: Transcat, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Transcat, Inc. (NASDAQ:TRNS) reported strong quarterly results, with revenues beating expectations by 7.4% and statutory profit significantly exceeding analyst forecasts. This positive performance has led analysts to increase their revenue and earnings per share estimates for 2027, indicating increased optimism for the company's future. Despite the upgraded earnings estimates, the consensus price target remains at US$104, though Transcat is expected to grow faster than the wider industry.
Transcat reports Q1 fiscal 2027 revenue up 21.6% to $92.9M, adjusted EPS $0.51
Transcat (TRNS) announced strong first quarter fiscal 2027 results, with consolidated revenue increasing 21.6% year-over-year to $92.9 million and service revenue growing 27.3% to $62.6 million. The company achieved an adjusted diluted EPS of $0.51 and an adjusted EBITDA of $13.96 million. Key highlights include significant service gross margin expansion and double-digit service organic revenue growth, demonstrating robust operational performance.
Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call
Transcat, Inc. (Nasdaq: TRNS) announced it will host a conference call and webcast on Tuesday, May 26, 2026, at 4:30 p.m. ET to discuss its financial results for the fourth quarter of fiscal year 2026, which ended March 28, 2026. President and CEO Jaime Irick and CFO Thomas Barbato will lead the call, reviewing results, corporate strategy, and outlook. A telephonic replay will be available until June 9, 2026, and the webcast replay and transcript will be accessible via the company's investor relations website.
Results: Transcat, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Transcat, Inc. (NASDAQ:TRNS) recently reported strong quarterly results, with revenues beating expectations by 7.4% and statutory profit significantly exceeding analyst forecasts. Following these positive results, analysts have increased their revenue and earnings per share estimates for 2027, indicating increased optimism for the company's future. Despite the upgraded earnings estimates, the consensus price target remains unchanged at US$104.
Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales
Transcat (NASDAQ:TRNS) reported strong Q2 CY2026 results, exceeding revenue and non-GAAP profit expectations with sales up 21.6% year-on-year to $92.95 million and an adjusted EPS of $0.51. Despite impressive revenue growth and market beats for EPS and EBITDA, the company's operating margin decreased, and long-term EPS growth has been unimpressive, raising concerns about profitability and efficiency. Analysts anticipate a deceleration in revenue growth over the next year.
Transcat (TRNS) Stock Faces Margin Questions After Revenue Growth
Transcat (TRNS) stock saw a modest increase after its Q1 2027 report, which highlighted strong revenue growth but raised concerns about declining net profit margins. While service revenue grew significantly and gross margin improved, net income and EPS decreased, leading to a trailing net profit margin of about 1% compared to 4.6% a year prior. The article suggests that while the company shows operational progress, factors like wage inflation and integration costs are compressing profitability, making timing crucial for investors.
Earnings call transcript: Transcat tops Q1 2026 with strong revenue growth
Transcat reported stronger-than-expected Q1 fiscal 2027 results, with adjusted diluted EPS of $0.51 and revenue of $92.9 million, driven by 27% service growth and 22% consolidated sales increase. The company's stock closed up 2.58% at $91.89, near its 52-week high, despite InvestingPro analysis suggesting it is overvalued. Management expressed confidence in continued high single-digit organic service growth and margin expansion, emphasizing operational excellence and strategic acquisitions.
Transcat Q1 2027 Earnings Call Transcript
Transcat reported a strong Q1 2027, with consolidated revenue up 22% to $92.9 million, driven by double-digit growth in both its service and distribution segments. Service revenue increased 27% with 13% organic growth, marking the 69th consecutive quarter of year-over-year service revenue growth. The company reaffirmed expectations for high-single-digit service organic growth and gross margin expansion for fiscal 2027, emphasizing continued strategic acquisitions and operational excellence.
Transcat Inc 2026: Revenue $92.95M, EPS $0.14— 10-Q Summary
Transcat Inc (TRNS) reported Q2 2026 results with revenue up 21.6% year over year to $92.95M, while net income decreased to $1.33M and diluted EPS to $0.14, due to acquisition-related costs and a shift in channel mix. Service revenue growth, especially in biomedical and client-based laboratories, and recent acquisitions drove the revenue increase. The company anticipates high single-digit organic service growth for fiscal 2027 and plans to focus on core calibration and selective M&A.
Transcat earnings beat by $0.02, revenue topped estimates
Transcat (NASDAQ: TRNS) reported first-quarter earnings per share of $0.51, surpassing analyst estimates of $0.49 by $0.02. The company's revenue for the quarter also exceeded expectations, coming in at $92.95 million against a consensus estimate of $84.96 million. Following these results, Transcat's stock price closed at $91.89, marking a 20.51% increase over the last three months and a 21.48% increase over the last 12 months.
Transcat reports Q1 fiscal 2027 revenue up 21.6% to $92.9M, adjusted EPS $0.51
Transcat reported strong financial results for Q1 fiscal 2027, with consolidated revenue increasing by 21.6% to $92.9 million and adjusted diluted EPS reaching $0.51. The company saw significant growth in service revenue, up 27.3%, and improved service gross margin, driven by its calibration business and operational efficiencies. Operating free cash flow also improved to $4.835 million, demonstrating strong operational cash generation.
Transcat (NASDAQ: TRNS) Q1 revenue up 21.6%, earnings down
Transcat, Inc. (NASDAQ: TRNS) reported a 21.6% increase in Q1 fiscal 2027 revenue, reaching $92.9 million, primarily driven by strong service revenue growth. Despite this, net income decreased by 59.2% to $1.3 million, or $0.14 per diluted share, due to a significant rise in operating expenses and interest expenses. The company also disclosed ongoing material weaknesses in its internal control over financial reporting, which affected the effectiveness of its disclosure controls.
Transcat (TRNS) Releases Q1 2027 Earnings: Revenue Rises 21.6% but Profit Falls
Transcat (TRNS) reported its Q1 2027 earnings, showing a 21.6% increase in revenue to $92.9 million, and gross profit up 19.0% to $30.7 million. Despite top-line growth, profitability declined significantly, with operating profit falling 30.3% and net income dropping 59.2%. The company experienced strong cash generation from operations, which surged 143.4% to $8.8 million.
Earnings Flash (TRNS) Transcat, Inc. Reports Q1 Revenue $92.9M, vs. FactSet Est of $86.6M
Transcat, Inc. (TRNS) has reported its Q1 revenue of $92.9 million, surpassing the FactSet estimate of $86.6 million. This financial update indicates a stronger-than-expected performance for the company in the first quarter. The article also mentions other recent company news, including an earnings call, adjusted EPS figures, and strategic appointments and acquisitions.
Earnings Flash (TRNS) Transcat, Inc. Posts Q1 Adjusted EPS $0.51 per Share, vs. FactSet Est of $0.38
Transcat, Inc. (TRNS) reported Q1 adjusted earnings per share of $0.51, surpassing FactSet's estimate of $0.38. This news follows their Q1 revenue report of $92.9 million, also exceeding FactSet's estimate of $86.6 million. The company, which provides calibration and related services, continues to expand, recently acquiring SCM Metrology and appointing a new CEO.
Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates
Transcat, Inc. (TRNS) reported strong first-quarter results, with earnings of $0.51 per share significantly beating the Zacks Consensus Estimate of $0.37, despite being lower than the $0.59 reported a year ago. The company also surpassed revenue expectations, posting $92.95 million against an estimated $86.42 million. While TRNS shares have seen a substantial 57.9% gain year-to-date, its current Zacks Rank of #3 (Hold) suggests it is expected to perform in line with the market in the near future.
What To Expect From Transcat’s (TRNS) Q2 Earnings
Transcat (TRNS) is set to announce its Q2 earnings this Tuesday afternoon. Analysts expect revenue growth of 13.3% year-on-year, a slowdown from the previous year, with estimates generally reconfirmed. Despite some peers in the maintenance and repair distributors segment showing solid performance, Transcat's share price is down 6.8% over the last month, heading into earnings with an average analyst price target of $101.33 against a current share price of $85.37.
What To Expect From Transcat’s (TRNS) Q2 Earnings
Transcat (TRNS) is set to announce its Q2 earnings, with analysts expecting a 13.3% year-on-year revenue growth, a slowdown from the previous year. The company missed revenue expectations last quarter but beat EBITDA estimates. Peers in the maintenance and repair distributors segment have shown mixed results, with WESCO exceeding expectations and MSC Industrial also beating estimates.
Transcat Number of Employees 2026 | Employee Count & Headcount Data
Transcat, Inc. (TRNS) had approximately 1,419 employees worldwide as of March 2026, representing a 4.7% growth from 2023. The company is actively hiring with 106 active job postings in 2026, a 50.9% increase from 2025. The workforce is primarily concentrated in North America, with an average salary of $77,550, though employee sentiment is negative and declining.
Transcat Inc (TRNS) Financial Health: Profitability & Balance Sheet Analysis
Transcat Inc (TRNS) has a stable financial status with an average operating efficiency, reflected in its current financial score of 7.29, ranking 30th in its industry. The company reported a 15.80% year-over-year increase in quarterly revenue to $89.33 million and a significant 56.38% year-over-year increase in net profit. While its financial health is stable, specific data for several financial dimensions like cash equivalents, operating profit, and free cash flow have not yet been disclosed by the company.
Transcat Inc (TRNS) Valuation: PE, PB & Fair Value Analysis
Transcat Inc (TRNS) currently holds a valuation score of 6.16, placing it 53rd out of 60 in the Electronic Equipment & Parts industry. Its P/E ratio is 98.13, which is below its recent high but significantly above its recent low. Other key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
